Skip to main content

Table 1 Demographics of patients

From: Analysis of SMN protein in umbilical cord blood and postnatal peripheral blood of neonates with SMA: a rationale for prompt treatment initiation to prevent SMA development

Pathological condition

 

Family 1

Family 2

Family 3

Family 4

Family 5

 

Sibling 1

Case 1

Sibling 2

Case 2

Sibling 3

Case 3

Sibling 4

Case 4

Sibling 5

Case 5

Sex

Male

Male

Female

Male

Female

Female

Male

Male

Male

Female

SMA type

Ia

Ia

Ia

Ib

Ib

Copy number of SMN2 (exon 7)

2

2

2

2

2

2

3

3

3

3

Gestational age at delivery

37w1d

37w0d

38w0d

38w3d

38w1d

Symptoms at birth

Diminished fetal activity

Deep tendon reflex( −)

Asymptomatic

Asymptomatic

Asymptomatic

Asymptomatic

Symptoms of the onset

Not acquired head control

Not acquired head control

Not acquired head control

Frequent stumbling

Loss of head control

Loss of head control

Frequent stumbling

Onset of SMA

At birth

 < 0y6m

0y4m

2y7m

0y4m

0y4m

3y11m

Procedure

Tracheostomy Gastrostoma

Tracheostomy Gastrostoma

Disease-modifying therapy (DMT)

DMT initiation (gestational age)

37w3d

37w2d

40w2d

40w1d

41w0d

Nusinersen

4y1m –5y0m

3d

0y6m –1y0m

3d

1y7m

3y3m –ongoing

Onasemnogene abeparvovec

11d

1y2m

15d

17d

15d

21d

Risdiplam

0y8m –ongoing

6y7m –ongoing

2y9m –ongoing

4y0m –ongoing

4y0m –ongoing

Present status

Deceased at 5y2m

Pulling to stand

Sitting without support

Normal motor function

Not acquired head control (bedridden)

Climbing stairs with support

Deceased at 1y4m

Normal motor function

Loss of head control (wheelchair)

normal motor function

Last observation (age)

5y2m

1y11m

3y4m

0y5m

6y3m

4y3m

1y4m

4y2m

8y4m

4y4m